References
- Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. (1974). Enzymatic determination of total serum cholesterol. J Clin Chem20: 470–475.
- Anderson N, Borlak J. (2008). Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev60(3): 311–357.
- Behrens H, Karber S. (1953). Determination of LD50. Arch. Fur Exp Path Pharm3: 177–372.
- Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE, Rudolph U, Mohler H. (2009). GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacol56: 174–181.
- Bent S, Padula A, Moore D, Patterson M, Mehling W. (2006). Valerian for sleep: a systematic review and meta-analysis. Am J Med119(12): 1005–12.
- Boullata JI, Nace AM. (2000). Safety Issues with Herbal Medicine: Common Herbal Medicines. Pharmacotherapy20(3): 64–71.
- Chopra RN, Nayar SL, Chopra IC. (1986). Glossary of Indian Medicinal Plants (Including the Supplement). New Delhi, India: Council of Scientific and Industrial Research. pp. 402–405.
- Chow NK, Fretz M, Hamburger M, Butterweck V. (2011). Telemetry as a tool to measure sedative effects of a valerian root extract and its single constituents in mice. Planta Med77: 795–803.
- Ciarlone AE, Smudski JW. (1977). Lidocaine’s influence on the accumulation and depletion rates of mouse brain amines. J Dental Res56 (11): 1391–1394.
- Denga Y, Caob M, Shia D. (2013). Toxicological evaluation of neem (Azadirachta indica) oil: acute and subacute toxicity. Environ Toxicol Pharmacol35: 240–246.
- Drupt F. (1974). Determination of serum albumin by bromocresol green. Pharma Biol8: 77–99.
- El Hilaly J, Israili ZH, Lyoussi B. (2004). Acute and chronic toxicological studies of Ajugaiva in experimental animals. J Ethnopharmacol91(1): 43–50.
- ESCOP (European Scientific Cooperative on Phytotherapy). (2003). Valeriana officinalis. In: ESCOP Monographs, 2nd edition. Stuttgart: Thieme. pp. 539–546.
- Gautam MK, Singh A, Rao CV, Goel RK. (2012). Toxicological evaluation of Murraya paniculata (L.) leaves extract on rodents. Am J Pharmacol Toxicol7(2): 62–67.
- Gornall AC, Bardawill CJ, David MM. (1949). Determination of serum proteins by means of the Biuret-reaction. J Biol Chem177: 751–766.
- Guide for the Care and Use of Laboratory Animals. Environment, Housing, and Management. (2011). National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press (US).; pp. 62–147.
- Hadley S, Petry JJ. (2003). Valerian. Am Fam Physician67(8): 1755–8.
- Hendriks H, Bos R, Woerdenbag HJ, Koster AS. (1985). Central nervous depressant activity of valerenic acid in the mouse. Planta Med51: 28–31.
- Houot O. (1985). Interpretation of clinical laboratory tests. Edited by Siest G, Henny J, Schiele F, Young DS. Biomed Pub.; pp. 220–234.
- Kabasakalian P, Kalliney S, Westcott A. (1973). Determination ofuric acid in serum, with use of uricase and atribromophenol-aminoantipyrine chromogen. Clin Chem19(5): 522–524.
- Kachkoul R, Sqalli Houssaini T, Miyah Y, Mohim M, El Habbani R, Lahrichi A. (2018). The study of the inhibitory effect of calcium oxalate monohydrate’s crystallization by two medicinal and aromatic plants: Ammi visnaga and Punica granatum. Prog Urol28(3): 156–16510.1016/j.purol.2017.12.00329325926
- Khom S, Baburin I, Timin E, Hohaus A, Trauner G, Kopp B, Hering S. (2007). Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity. Neuropharmacol53: 178–187.
- Khom S, Strommer B, Ramharter J, Schwarz T, Schwarzer C, Erker T, Ecker GF,Mulzer J, Hering S. (2010). Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands – in vitro and in vivo characterization. Br J Pharmacol161: 65–78.
- Kind PRN, King EG. (1954). Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino antipyrine. J Clin Pathol7: 322–326.
- Koriem KM, Arbid MS, El-Gendy NF. (2010). The protective role of Tropaeolum majus on blood and liver toxicity induced by diethyl maleate in rats. Toxicol Mech Methods20: 579–586.
- Marder M, Viola H, Wasowski C, Fernández S, Medina JH, Paladini AC. (2003). 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav75(3): 537–45.
- Maruyama Y, Aoki N, Suzuki Y, Ohno,Y, Imamura M, Saika T, Sinohara H, Yamamoto T. (1987). Sex-steroid-binding plasma protein SBP, testosterone, oestradiol and dehydroepiandrosterone DHEA in prepuberty and puberty. Acta Endocrinol. Copenhagen1141: 60–67.
- Mukinda JT, Eagles PFK. (2010). Acute and sub-chronic oral toxicity profiles of the aqueous extract of Polygala fruticosa in female mice and rats J Ethnopharmacol128(1): 236–240.10.1016/j.jep.2010.01.02220079821
- Mukinda JT, Syce JA. (2007). Acute and chronic toxicity of the aqueous extract of Artemisia afra in rodents. J Ethnopharmacol112(1): 138–144.
- Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH. (2010). Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine17: 674–678.
- Neuhaus W, Trauner G, Gruber D, Oelzant S, Klepal W, Kopp B, Noe CR. (2008). Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier. Planta Med74: 1338–1344
- OECD. (2001). Acute Oral Toxicity: Acute Toxic Class Method. Test Guideline. pp. 423–435.
- OECD. (2008). Repeated Dose 28-day oral toxicity study in rodents In “OECD Guidelines For the Testing of Chemicals, Section 4: Health Effects” OECD Publishing.
- Olson H, Betton G, Robinson D. (2000). Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulat Toxicol Pharmacol32(1): 56–67.
- Patočka, J, Jakl J. (2010). Biomedically relevant chemical constituents of Valeriana officinalis. J Appl Biomed8(1): 11–18.
- Patton CJ, Crouch SR. (1977). Spectrophotometric and kinetic investigation of the Berthelot reaction for the determination of ammonia. Anal Chem49: 464–469.
- Pavela R, Vrchotová N, Tříska J. (2016). Larvicidal activity of extracts from Ammi visnaga Linn. (Apiaceae) seeds against Culex quinquefasciatus Say. (Diptera: Culicidae). Exp Parasitol. 165: 51–7.
- Rahman MF. (2001). Effects of Vepacide (Azadirachta indica) on aspartate and alanine aminotransferase profiles in a subchronic study with rats. Human Exper Toxicol20(5): 243–249.
- Reitman S, Frankel S. (1957). A colorimetric method for the determination of serum glutamic oxaloacetic acid and glutamic pyruvic transaminases. Am J Clin Pathol28: 56–63.
- Roch ABD, Lopes RM, Schwartsmann G. (2001). Natural products in anticancer therapy. Curr Opin Pharmacol1: 364–369.
- Rodak LC. (1995). Routing testing in haematology in: Dignostic haematology W.B. Saunders Comp. Philadelphia London, Toronto; pp.128–144.
- Saad B, Azaizeh H, Abu-Hijleh G, Said O. (2006). Safety of traditional Arab herbal medicine. Evidence-Based Complemen Altern Med3(4): 433–439.
- Talalay P. (1962). Hydroxysteroid dehydrogenase. In: Cloowick, S.P., Kaplan (Eds.), Methods in Enzymology, vol. 11. Academic Press, NY, pp. 512–516.
- Travaini ML, Sosa GM, Ceccarelli EA, Walter H, Cantrell CL, Carrillo NJ, Dayan FE, Meepagala KM, Duke SO. (2016). Khellin and Visnagin, Furanochromones from Ammi visnaga (L.) Lam., as Potential Bioherbicides. J Agric Food Chem.64(50): 9475–9487.
- Trinder P. (1969). Determination of glucose in blood using glucoseoxidase with an alternative oxygen acceptor. Ann Clin Biochem6: 24–27.
- Vanachayangkul P, Byer K, Khan S, Butterweck V. (2010). An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells. Phytomedicine17(0): 653–658.
- Van Kampen E, Zijlstra WG. (1961). Standardization of hemoglobinometry. II. The hemoglobin cyanide method. Clin Chim Acta6: 538–544.
- Vihma V, Adlercreutz H, Tiitinen A, Kiuru P, Wähälä K, Tikkanen MJ. (2001). Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid. Clin Chem47(7): 1256–1262.
- Waltenberger B, Mocan A, Šmejkal K, Heiss EH, Atanasov AG. (2016). Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders. Molecules21(6): 33 pages.
- Walter M, Gerarde H. (1970). Ultra micro method for the determination of conjugated and total bilirubin in serum or plasma. Microchem J15: 231–238.
- Weeks, Benjamin S. (2009). Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian™. Med Sci Monit15 (11): RA256–262.
- WHO (World Health Organization). (2008). WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems, WHO (World Health Organization), Geneva, Switzerland, pp. 105–114.
- Wills RBH, Shohet D. (2009). Changes in valerenic acids content of valerian root (Valeriana officinalis L. s.l.) during long-term storage. Food Chem115 (1): 250–253.
- Yakob HK, Uyub AM, Sulaiman SF. (2012). Toxicological evaluation of 80% methanol extract of Ludwigia octovalvis (Jacq.) P.H. Raven leaves (Onagraceae) in BALB/c mice. J Ethnopharmacol142: 663–668.